Literature DB >> 15115140

Stability of meropenem in normal saline solution after storage at room temperature.

Sutep Jaruratanasirikul1, Somchai Sriwiriyajan.   

Abstract

The bactericidal activity of meropenem is determined by the time that concentrations in tissue and serum are above the MIC for the pathogens during the dosing interval. Thus, the most effective mode of administering of meropenem is continuous infusion. However, the stability of meropenem reconstituted in solution is influenced by the storage temperature. Until now we have had no data to evaluate the stability of this drug during continuous infusion in a tropical country. The objective of this study was to provide such data. Meropenem 0.5 g and 100 ml normal saline solution were mixed together and stored at room temperature for 8 hours. Half of the solution was stored in a room with air conditioning at 20 degrees C and the other half of the solution was stored in a room without air conditioning at 32 degrees-37 degrees C. The concentrations of meropenem in the solution were measured at 0, 1, 2, 3, 4, 6 and 8 hours after the drug was reconstituted. Twelve lots of (0.5 g meropenem in normal saline) solution were evaluated in each temperature condition. The mean meropenem concentrations reconstituted in normal saline solution decreased 1.66%, 3.31% and 5.80% after 2, 4 and 8 hours storage at 20 degrees C, respectively. Drug concentrations decreased 3.14%, 5.86% and 11.85% after 2, 4 and 8 hours storage at 32 degrees-37 degrees C, respectively. Therefore, we conclude that this agent should not be administered by 8-hour continuous infusion at room temperature in a tropical country.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15115140

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  10 in total

1.  In Vitro Stabilifighty Evaluation of Different Pharmaceutical Products Containing Meropenem.

Authors:  Cristina Tomasello; Anna Leggieri; Roberta Cavalli; Giovanni Di Perri; Antonio D'Avolio
Journal:  Hosp Pharm       Date:  2015-04-08

2.  Comparison of the pharmacodynamics of meropenem in patients with ventilator-associated pneumonia following administration by 3-hour infusion or bolus injection.

Authors:  Sutep Jaruratanasirikul; Somchai Sriwiriyajan; Jarurat Punyo
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

3.  Stability of Meropenem After Reconstitution for Administration by Prolonged Infusion.

Authors:  Sarah Fawaz; Stephen Barton; Laura Whitney; Julian Swinden; Shereen Nabhani-Gebara
Journal:  Hosp Pharm       Date:  2018-05-30

4.  Determination of meropenem in bacterial media by LC-MS/MS.

Authors:  Liusheng Huang; Janus Haagensen; Davide Verotta; Patricia Lizak; Francesca Aweeka; Katherine Yang
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-05-14       Impact factor: 3.205

Review 5.  Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis.

Authors:  Jason A Roberts; Jeffrey Lipman
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

6.  Pharmacokinetics of meropenem during intermittent and continuous intravenous application in patients treated by continuous renal replacement therapy.

Authors:  Julia Langgartner; Antje Vasold; Thomas Glück; Michel Reng; Frieder Kees
Journal:  Intensive Care Med       Date:  2008-02-23       Impact factor: 17.440

7.  Stability, compatibility and microbiological activity studies of meropenem-clavulanate potassium.

Authors:  Judyta Cielecka-Piontek; Daria Szymanowska-Powałowska; Magdalena Paczkowska; Piotr Łysakowski; Przemysław Zalewski; Piotr Garbacki
Journal:  J Antibiot (Tokyo)       Date:  2014-07-30       Impact factor: 2.649

8.  500 mg as bolus followed by an extended infusion of 1500 mg of meropenem every 8 h failed to achieve in one-third of the patients an optimal PK/PD against non-resistant strains of these organisms: is CRRT responsible for this situation?

Authors:  Patrick M Honore; Leonel Barret Gutierrez; Luc Kugener; Sebastien Redant; Rachid Attou; Andrea Gallerani; David De Bels
Journal:  Ann Intensive Care       Date:  2020-12-03       Impact factor: 6.925

9.  High Cefuroxime Concentrations and Long Elimination in an Orthopaedic Surgical Deadspace-A Microdialysis Porcine Study.

Authors:  Sara Kousgaard Tøstesen; Maiken Stilling; Pelle Hanberg; Theis Muncholm Thillemann; Thomas Falstie-Jensen; Mikkel Tøttrup; Martin Knudsen; Emil Toft Petersen; Mats Bue
Journal:  Antibiotics (Basel)       Date:  2022-02-07

10.  Continuous infusions of meropenem in ambulatory care: clinical efficacy, safety and stability.

Authors:  Laurens Manning; Cameron Wright; Paul R Ingram; Timothy J Whitmore; Christopher H Heath; Ingrid Manson; Madhu Page-Sharp; Sam Salman; John Dyer; Timothy M E Davis
Journal:  PLoS One       Date:  2014-07-14       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.